Literature DB >> 17532193

Neural substrates of olfactory processing in schizophrenia patients and their healthy relatives.

Frank Schneider1, Ute Habel, Martina Reske, Ivan Toni, Peter Falkai, N Jon Shah.   

Abstract

Odorants represent powerful stimuli capable of eliciting various emotional responses. In schizophrenia patients and their non-affected relatives, olfactory and emotional functions are impaired, revealing a familial influence on these deficits. We aimed at determining the neural basis of emotional olfactory dysfunctions using odors of different emotional valence for mood induction and functional magnetic resonance imaging (fMRI) by comparing 13 schizophrenia patients, their non-affected brothers and 26 matched healthy controls. Blood-oxygen-level-dependent (BOLD) effects and subjective mood changes were assessed during negative (rotten yeast), positive (vanilla) and neutral (ambient air) olfactory stimulation. Group comparisons of brain activation were performed in regions of interest. Subjective ratings were comparable between groups and indicated successful mood induction. However, during stimulation with the negative odor, hypofunctional activity emerged in regions of the right frontal and temporal cortex in the patients. A familial influence in the neural substrates of negative olfactory dysfunction was indicated by a similar reduced frontal brain activity in relatives. Dysfunctions therefore appeared to be located in regions involved in higher cognitive processes associated with olfaction. No familial influences were indicated for cerebral dysfunctions during positive olfactory stimulation. Results point to a differentiation between trait and state components in cerebral dysfunctions during emotional olfactory processing in schizophrenia.

Entities:  

Mesh:

Year:  2007        PMID: 17532193     DOI: 10.1016/j.pscychresns.2006.12.004

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  26 in total

1.  Olfactory processing in schizophrenia, non-ill first-degree family members, and young people at-risk for psychosis.

Authors:  Vidyulata Kamath; Bruce I Turetsky; Monica E Calkins; Christian G Kohler; Catherine G Conroy; Karin Borgmann-Winter; Dana E Gatto; Raquel E Gur; Paul J Moberg
Journal:  World J Biol Psychiatry       Date:  2011-11-10       Impact factor: 4.132

Review 2.  Goal representations and motivational drive in schizophrenia: the role of prefrontal-striatal interactions.

Authors:  Deanna M Barch; Erin C Dowd
Journal:  Schizophr Bull       Date:  2010-06-21       Impact factor: 9.306

3.  Amygdala recruitment in schizophrenia in response to aversive emotional material: a meta-analysis of neuroimaging studies.

Authors:  Alan Anticevic; Jared X Van Snellenberg; Rachel E Cohen; Grega Repovs; Erin C Dowd; Deanna M Barch
Journal:  Schizophr Bull       Date:  2010-12-01       Impact factor: 9.306

Review 4.  Imaging genetic liability to schizophrenia: systematic review of FMRI studies of patients' nonpsychotic relatives.

Authors:  Angus W MacDonald; Heidi W Thermenos; Deanna M Barch; Larry J Seidman
Journal:  Schizophr Bull       Date:  2008-06-12       Impact factor: 9.306

5.  Emotion effects on attention, amygdala activation, and functional connectivity in schizophrenia.

Authors:  Alan Anticevic; Grega Repovs; Deanna M Barch
Journal:  Schizophr Bull       Date:  2011-03-17       Impact factor: 9.306

6.  Amygdala abnormalities in first-degree relatives of individuals with schizophrenia unmasked by benzodiazepine challenge.

Authors:  Daniel H Wolf; Theodore D Satterthwaite; James Loughead; Amy Pinkham; Eve Overton; Mark A Elliott; Gersham W Dent; Mark A Smith; Ruben C Gur; Raquel E Gur
Journal:  Psychopharmacology (Berl)       Date:  2011-05-21       Impact factor: 4.530

Review 7.  Olfactory function in psychotic disorders: Insights from neuroimaging studies.

Authors:  Kimberley P Good; Randii Lynn Sullivan
Journal:  World J Psychiatry       Date:  2015-06-22

8.  Anhedonia and emotional experience in schizophrenia: neural and behavioral indicators.

Authors:  Erin C Dowd; Deanna M Barch
Journal:  Biol Psychiatry       Date:  2009-12-09       Impact factor: 13.382

Review 9.  The motivation and pleasure dimension of negative symptoms: neural substrates and behavioral outputs.

Authors:  Ann M Kring; Deanna M Barch
Journal:  Eur Neuropsychopharmacol       Date:  2014-01-22       Impact factor: 4.600

10.  Effects of aversive odour presentation on inhibitory control in the Stroop colour-word interference task.

Authors:  Andreas Finkelmeyer; Thilo Kellermann; Daniela Bude; Thomas Niessen; Michael Schwenzer; Klaus Mathiak; Martina Reske
Journal:  BMC Neurosci       Date:  2010-10-18       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.